Subtopic Deep Dive
Inflammatory Mechanisms Cisplatin Kidney Injury
Research Guide
What is Inflammatory Mechanisms Cisplatin Kidney Injury?
Inflammatory mechanisms in cisplatin kidney injury involve NF-κB activation, TNF-α mediated cytokine storms, and leukocyte infiltration driving tubulointerstitial damage in acute kidney injury.
Cisplatin nephrotoxicity triggers renal inflammation via TNF-α upregulation and chemokine expression, leading to severe kidney failure (Ramesh and Reeves, 2002, 751 citations). Key studies detail NF-κB pathways and ICAM-1 adhesion molecule roles in leukocyte recruitment (Pabla and Dong, 2008, 1837 citations; Miller et al., 2010, 1565 citations). Over 10 papers from the list examine these processes, with recent reviews confirming inflammation's amplification of platinum toxicity (Tang et al., 2022, 405 citations).
Why It Matters
Inflammation exacerbates cisplatin-induced acute kidney injury, limiting its use in ovarian, head, and neck cancer treatments, where nephrotoxicity affects up to 30% of patients (Özkök and Edelstein, 2014, 678 citations). Suppressing TNF-α reduces renal damage while preserving antitumor efficacy, as shown in mouse models with 20 mg/kg cisplatin doses (Ramesh and Reeves, 2002). Mesenchymal stem cell microvesicles mitigate lethal AKI by countering inflammatory cytokines, improving survival (Bruno et al., 2012, 601 citations). Targeting these mechanisms via anti-inflammatory agents like dexamethasone enhances chemotherapy's therapeutic index in clinical oncology.
Key Research Challenges
Quantifying cytokine contributions
Distinguishing direct cisplatin effects from secondary TNF-α driven inflammation remains difficult in vivo (Ramesh and Reeves, 2002). Models show cytokine knockout reduces injury, but human translation lacks biomarkers (Miller et al., 2010). Over 750 citations highlight persistent gaps in causal pathways (Pabla and Dong, 2008).
Balancing renoprotection and efficacy
Anti-inflammatory interventions risk tumor protection, as cisplatin cytotoxicity relies on similar NF-κB responses (Volarević et al., 2019). Studies balance kidney repair against oncology outcomes, with microvesicles showing promise without efficacy loss (Bruno et al., 2012). Recent advances note knife-edge molecular trade-offs (Tang et al., 2022).
Translating preclinical inflammation models
Mouse AKI models at 20 mg/kg cisplatin overstate human inflammatory responses, complicating clinical trials (Manohar and Leung, 2017). Leukocyte infiltration and ICAM-1 data rarely predict patient nephrotoxicity (Özkök and Edelstein, 2014). Holditch et al. (2019) cite needs for better biomarkers.
Essential Papers
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Navjotsingh Pabla, Zheng Dong · 2008 · Kidney International · 1.8K citations
Mechanisms of Cisplatin Nephrotoxicity
Ronald Miller, Raghu Tadagavadi, Ganesan Ramesh et al. · 2010 · Toxins · 1.6K citations
Cisplatin is a widely used and highly effective cancer chemotherapeutic agent. One of the limiting side effects of cisplatin use is nephrotoxicity. Research over the past 10 years has uncovered man...
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ganesan Ramesh, William Reeves · 2002 · Journal of Clinical Investigation · 751 citations
The purpose of these studies was to examine the role of cytokines in the pathogenesis of cisplatin nephrotoxicity. Injection of mice with cisplatin (20 mg/kg) led to severe renal failure. The expre...
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Özkök, Charles L. Edelstein · 2014 · BioMed Research International · 678 citations
Cisplatin and other platinum derivatives are the most widely used chemotherapeutic agents to treat solid tumors including ovarian, head and neck, and testicular germ cell tumors. A known complicati...
Cisplatin nephrotoxicity: a review of the literature
Sandhya Manohar, Nelson Leung · 2017 · Journal of Nephrology · 610 citations
Cisplatin is a platinum containing drug first approved as an antineoplastic agent in 1978. It remains an important and effective therapy in many forms of cancer today. Cisplatin mediates its tumorc...
Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury
Stefania Bruno, Cristina Grange, Federica Collino et al. · 2012 · PLoS ONE · 601 citations
Several studies demonstrated that treatment with mesenchymal stem cells (MSCs) reduces cisplatin mortality in mice. Microvesicles (MVs) released from MSCs were previously shown to favor renal repai...
Cellular Responses to Cisplatin‐Induced DNA Damage
Alakananda Basu, Soumya Krishnamurthy · 2010 · Journal of Nucleic Acids · 551 citations
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging DNA and in...
Reading Guide
Foundational Papers
Start with Pabla and Dong (2008, 1837 citations) for core mechanisms overview, then Ramesh and Reeves (2002, 751 citations) for TNF-α evidence, followed by Miller et al. (2010, 1565 citations) for cellular details.
Recent Advances
Tang et al. (2022, 405 citations) updates therapeutic implications; Holditch et al. (2019, 345 citations) covers biomarkers; Volarević et al. (2019, 405 citations) balances renoprotection.
Core Methods
Mouse cisplatin injection (20 mg/kg) assays cytokines/chemokines by qPCR/Western blot; histology quantifies leukocyte infiltration/ICAM-1; stem cell microvesicles tested for survival in lethal AKI (Ramesh and Reeves, 2002; Bruno et al., 2012).
How PapersFlow Helps You Research Inflammatory Mechanisms Cisplatin Kidney Injury
Discover & Search
Research Agent uses searchPapers('inflammatory mechanisms cisplatin nephrotoxicity TNF-alpha') to retrieve Ramesh and Reeves (2002), then citationGraph reveals 751 downstream papers on cytokine storms. findSimilarPapers on Pabla and Dong (2008) uncovers 1837-cited mechanisms, while exaSearch scans 250M+ OpenAlex papers for NF-κB specifics.
Analyze & Verify
Analysis Agent applies readPaperContent to extract TNF-α expression data from Ramesh and Reeves (2002), then verifyResponse with CoVe cross-checks claims against Miller et al. (2010). runPythonAnalysis plots cytokine levels from paper tables using pandas, with GRADE scoring evidence as high for mouse models.
Synthesize & Write
Synthesis Agent detects gaps in human translation from Özkök and Edelstein (2014), flags contradictions between stem cell repair (Bruno et al., 2012) and toxicity reviews. Writing Agent uses latexEditText for inflammation pathway edits, latexSyncCitations integrates 10 key papers, and latexCompile generates review sections with exportMermaid for NF-κB diagrams.
Use Cases
"Plot TNF-α levels vs renal injury in cisplatin mouse models from Ramesh 2002"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot from extracted tables) → matplotlib figure of cytokine curves vs BUN levels.
"Draft LaTeX review on inflammatory cisplatin nephrotoxicity mechanisms"
Synthesis Agent → gap detection on Pabla Dong 2008 → Writing Agent → latexEditText + latexSyncCitations (10 papers) → latexCompile → PDF with NF-κB pathway figure.
"Find code for simulating cisplatin inflammation models"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for cytokine network simulations.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'cisplatin TNF-alpha kidney', producing structured reports with GRADE-scored inflammation mechanisms from Ramesh and Reeves (2002). DeepScan's 7-step chain verifies NF-κB data across Pabla and Dong (2008) with CoVe checkpoints. Theorizer generates hypotheses on microvesicle anti-inflammatory actions from Bruno et al. (2012).
Frequently Asked Questions
What defines inflammatory mechanisms in cisplatin kidney injury?
NF-κB activation, TNF-α cytokine storms, and leukocyte infiltration via ICAM-1 cause tubulointerstitial damage post-cisplatin (Ramesh and Reeves, 2002; Pabla and Dong, 2008).
What are key methods studying these mechanisms?
Mouse models use 20 mg/kg cisplatin to measure kidney cytokines, chemokines, and renal failure markers like BUN (Miller et al., 2010; Ramesh and Reeves, 2002).
What are the most cited papers?
Pabla and Dong (2008, 1837 citations) reviews mechanisms; Miller et al. (2010, 1565 citations) details cellular pathways; Ramesh and Reeves (2002, 751 citations) proves TNF-α causality.
What open problems exist?
Human biomarkers for inflammation lack validation; renoprotective agents risk tumor protection; preclinical models overpredict severity (Holditch et al., 2019; Volarević et al., 2019).
Research Chemotherapy-induced organ toxicity mitigation with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Inflammatory Mechanisms Cisplatin Kidney Injury with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers